Evidence map›Paper›PMID 39719504›Full record

ArticleInternational journal of hematology2025

A 25-year clonal resurrection in adult T-cell leukemia-lymphoma relapse.

Atae Utsunomiya, Jun-Ichirou Yasunaga, Tomohisa Tabuchi, Nobuaki Nakano, Jun Odawara, Ayumu Kubota, Masahito Tokunaga, Takayoshi Miyazono, Masao Matsuoka, Yoshikiyo Ito and 1 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Atae UtsunomiyaDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan. autsunomiya@jiaikai.jp.ORCID http://orcid.org/0000-0002-8843-406X
Jun-Ichirou YasunagaDepartment of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Tomohisa TabuchiDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Nobuaki NakanoDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Jun OdawaraDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Ayumu KubotaDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Masahito TokunagaDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Takayoshi MiyazonoDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Masao MatsuokaDepartment of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yoshikiyo ItoDepartment of Hematology, Imamura General Hospital, 11-23, Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Yukie TashiroDepartment of Pathology, Imamura General Hospital, Kagoshima, Japan.

Funding

Japan Agency for Medical Research and Development 24ck0106742h0003
6 · The paper itself

Abstract

Here, we report a rare case of relapsed adult T-cell leukemia-lymphoma (ATL) with evidence of clonal relapse 26 years after initial diagnosis. The patient had been diagnosed with an aggressive form of lymphoma-type ATL 26 years prior and did not receive further ATL treatment for approximately 26 years after achieving complete remission. We used nested PCR to identify the amplification of ATL clone-specific accumulation sites in DNA from hematoxylin and eosin-stained specimens from the patient. Furthermore, the sequence of amplicons obtained from peripheral blood mononuclear cells and lymphoma cells from the previously diagnosed ATL were identical, indicating that a human T-cell leukemia virus-type 1 (HTLV-1)-infected clone identical to the one that recently caused ATL was present in the original lymphoma tissue. Although we were unable to identify this clone as the cause of the previous ATL, the peripheral leukemia cells revealed an ATL clone that was present in the tumor cells of a lymph node diagnosed 26 years earlier. To our knowledge, this is the first report demonstrating survival of HTLV-1-infected clones for a quarter of a century in a patient with recurrent ATL.

Indexed as

Human T-lymphotropic virus 1Leukemia-Lymphoma, Adult T-CellAged, 80 and overClone CellsHumansMaleRecurrenceATLATL clone-specific integrationLong survival of HTLV-1 infected clones

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.